SCHEMBL4910751

SCHEMBL4910751

O=C(COc1cccc(Cl)c1)Nc1ccc(F)cc1C(=O)O

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SERPINE1 P05121 1/20 0.60
POLB P06746 1/20 0.58
G6PD P11413 1/20 0.58
DVL1 O14640 1/20 0.56
NPC1 O15118 1/20 0.56
RAB9A P51151 1/20 0.56
L3MBTL1 Q9Y468 1/20 0.56
TP53 P04637 2/20 0.54
GAA P10253 1/20 0.54
ALOX12 P18054 1/20 0.54
SMN1; SMN2 Q16637 1/20 0.53
MEN1 O00255 2/20 0.52
KMT2A Q03164 2/20 0.52
THRB P10828 1/20 0.52
ALDH1A1 P00352 1/20 0.52
CYP1A2 P05177 1/20 0.52
CYP3A4 P08684 1/20 0.52
CYP2C9 P11712 1/20 0.52
CYP2C19 P33261 1/20 0.52
TRPM4 Q8TD43 2/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4914734 0.88 SERPINE1 (0.62) SERPINE1POLBG6PDDVL1NPC1
SCHEMBL4905494 0.85 MEN1 (0.69) SERPINE1POLBG6PDNPC1RAB9A
SCHEMBL29575524 0.81 SERPINE1 (0.66) SERPINE1POLBG6PDDVL1NPC1
SCHEMBL419348 0.81 SERPINE1 (0.79) SERPINE1POLBG6PDDVL1NPC1
SCHEMBL3561252 0.80 NOTUM (0.55) SERPINE1POLBG6PDDVL1NPC1
SCHEMBL29838604 0.79 SERPINE1 (0.63) SERPINE1POLBG6PDDVL1NPC1
SCHEMBL421005 0.79 SERPINE1 (0.63) SERPINE1POLBG6PDDVL1NPC1
SCHEMBL418268 0.77 SERPINE1 (0.66) SERPINE1POLBG6PDNPC1RAB9A
SCHEMBL4905601 0.77 HCAR2 (0.58) SERPINE1POLBG6PDDVL1NPC1
SCHEMBL4914768 0.77 KDM4E (0.59) SERPINE1POLBG6PDDVL1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080269333-A1 ANTHRANILIC ACID DERIVATIVES USEFUL IN TREATING INFECTION WITH HEPATITIS C VIRUS WYETH (US) 2008-10-30 US claimed
US-7408078-B2 Anthranilic acid derivatives useful in treating infection with hepatitis C virus WYETH (US) 2008-08-05 US claimed
US-20050004192-A1 Anthranilic acid derivatives useful in treating infection with hepatitis C virus VIROPHARMA INCORPORATED 2005-01-06 US claimed
US-20080269333-A1 ANTHRANILIC ACID DERIVATIVES USEFUL IN TREATING INFECTION WITH HEPATITIS C VIRUS WYETH (US) 2008-10-30 US disclosed
US-7408078-B2 Anthranilic acid derivatives useful in treating infection with hepatitis C virus WYETH (US) 2008-08-05 US disclosed
US-20050004192-A1 Anthranilic acid derivatives useful in treating infection with hepatitis C virus VIROPHARMA INCORPORATED 2005-01-06 US disclosed
WO-2004091724-A1 ANTHRANILIC ACID DERIVATIVES USEFUL IN TREATING INFECTION WITH HEPATITIS C VIRUS WYETH (US) 2004-10-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050004192-A1 Anthranilic acid derivatives useful in treating infection with hepatitis C virus HCCS, ALAD, HAVCR2 SERPINE1 2533/4885POLB 4391/4885G6PD 362/4885
US-20080269333-A1 ANTHRANILIC ACID DERIVATIVES USEFUL IN TREATING INFECTION WITH HEPATITIS C VIRUS HCCS, ALAD, HAVCR2 SERPINE1 2533/4885POLB 4391/4885G6PD 362/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.